Production (Stage)
Aldeyra Therapeutics, Inc.
ALDX
$2.22
-$0.03-1.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -92.27% | -48.77% | 1.96% | 27.26% | 50.69% |
| Total Depreciation and Amortization | -2.54% | -5.02% | -4.26% | -3.61% | -2.47% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 112.16% | 6.36% | -49.43% | -72.68% | -69.83% |
| Change in Net Operating Assets | 204.18% | 586.70% | 241.52% | 164.98% | -27.01% |
| Cash from Operations | -48.13% | -42.48% | 27.07% | 34.08% | 42.01% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 76.14% | -249.72% | -176.06% | -163.95% | -152.30% |
| Cash from Investing | 76.14% | -249.72% | -176.06% | -163.95% | -152.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 71.94% | 71.94% | -- | -- | -- |
| Issuance of Common Stock | 406.83% | 27.22% | -75.17% | -78.83% | -78.32% |
| Repurchase of Common Stock | -- | -- | 100.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 162.33% | 86.51% | -362.00% | -204.40% | -204.42% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 16.62% | -5,430.94% | -612.21% | -363.00% | -1,122.05% |